ACM Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $4.83M

ACM Biosciences General Information

Description

Developer of infectious disease vaccines designed to provide safe and effective vaccines designed using polymersome technology. The company's therapeutic vaccine provides an enhanced immune response in preclinical trials, the polymersome technology provides advantages in manufacturability and enhances the durability of vaccines, also the polymersome does not suffer from vector-neutralizing antibodies, is stable for easy storage and shipping and does not need a complex cold chain, enabling the medical industry to get a flexible, scalable, easy to manufacture and efficacious vaccine medium for preventing various illnesses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • Aeschenplatz 6
  • 4052 Basel
  • Switzerland
+41 061
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Aeschenplatz 6
  • 4052 Basel
  • Switzerland
+41 061

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACM Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 07-Apr-2021 $4.83M Completed Startup
To view ACM Biosciences’s complete valuation and funding history, request access »

ACM Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
To view ACM Biosciences’s complete cap table history, request access »

ACM Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACM Biosciences FAQs

  • When was ACM Biosciences founded?

    ACM Biosciences was founded in 2020.

  • Where is ACM Biosciences headquartered?

    ACM Biosciences is headquartered in Basel, Switzerland.

  • What is the size of ACM Biosciences?

    ACM Biosciences has 6 total employees.

  • What industry is ACM Biosciences in?

    ACM Biosciences’s primary industry is Drug Discovery.

  • Is ACM Biosciences a private or public company?

    ACM Biosciences is a Private company.

  • What is the current valuation of ACM Biosciences?

    The current valuation of ACM Biosciences is .

  • What is ACM Biosciences’s current revenue?

    The current revenue for ACM Biosciences is .

  • How much funding has ACM Biosciences raised over time?

    ACM Biosciences has raised $4.83M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »